DK2081944T3 - Nye morfin-derivater - Google Patents

Nye morfin-derivater

Info

Publication number
DK2081944T3
DK2081944T3 DK07858552.8T DK07858552T DK2081944T3 DK 2081944 T3 DK2081944 T3 DK 2081944T3 DK 07858552 T DK07858552 T DK 07858552T DK 2081944 T3 DK2081944 T3 DK 2081944T3
Authority
DK
Denmark
Prior art keywords
morphine derivatives
new morphine
new
derivatives
pharmaceutical compositions
Prior art date
Application number
DK07858552.8T
Other languages
English (en)
Inventor
Karine Larbouret
Roger Lahana
Cedric Castex
Original Assignee
Neorphys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorphys filed Critical Neorphys
Application granted granted Critical
Publication of DK2081944T3 publication Critical patent/DK2081944T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rheumatology (AREA)
  • Saccharide Compounds (AREA)
DK07858552.8T 2006-10-12 2007-10-11 Nye morfin-derivater DK2081944T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0654247A FR2907121B1 (fr) 2006-10-12 2006-10-12 Nouveaux derives morphiniques
PCT/FR2007/052122 WO2008043962A1 (fr) 2006-10-12 2007-10-11 Nouveaux derives morphiniques

Publications (1)

Publication Number Publication Date
DK2081944T3 true DK2081944T3 (da) 2010-09-20

Family

ID=38038630

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07858552.8T DK2081944T3 (da) 2006-10-12 2007-10-11 Nye morfin-derivater

Country Status (21)

Country Link
US (1) US8158764B2 (da)
EP (1) EP2081944B1 (da)
JP (1) JP5180219B2 (da)
KR (1) KR20090079232A (da)
CN (1) CN101522700B (da)
AT (1) ATE473233T1 (da)
AU (1) AU2007306226C1 (da)
CA (1) CA2664569A1 (da)
CY (1) CY1110787T1 (da)
DE (1) DE602007007653D1 (da)
DK (1) DK2081944T3 (da)
ES (1) ES2347020T3 (da)
FR (1) FR2907121B1 (da)
HK (1) HK1131156A1 (da)
IL (1) IL197769A (da)
PL (1) PL2081944T3 (da)
PT (1) PT2081944E (da)
RU (1) RU2426736C2 (da)
SI (1) SI2081944T1 (da)
WO (1) WO2008043962A1 (da)
ZA (1) ZA200903193B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2318687A (en) 1943-05-11 Means fob determining the sex of
US4939264A (en) * 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
WO1997021416A2 (es) * 1995-11-29 1997-06-19 Rolabo Sl Glicoconjugados de substancias opiaceas
DE19602964A1 (de) 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
AU723859B2 (en) 1997-04-14 2000-09-07 Ufc Limited Morphine derivatives
GB9711118D0 (en) * 1997-05-29 1997-07-23 Rolabo Sl Compound
CA2332974C (en) 1998-06-06 2009-03-10 Cenes Limited Morphine-6-glucuronide synthesis
FR2821272B1 (fr) * 2001-02-23 2004-12-17 Synt Em Composes constitues d'une molecule analgesique liee a un vecteur capable de vectoriser ladite molecule a travers la barriere hematoencephalique et compositions pharmaceutiques les contenant
WO2002074241A2 (en) 2001-03-16 2002-09-26 Dmi Biosciences Inc. Method of delaying ejaculation
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
AU2005323534A1 (en) * 2005-01-05 2006-07-13 Philip S. Portoghese Analgesic conjugates
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Also Published As

Publication number Publication date
CN101522700B (zh) 2012-08-22
CN101522700A (zh) 2009-09-02
EP2081944B1 (fr) 2010-07-07
RU2426736C2 (ru) 2011-08-20
JP5180219B2 (ja) 2013-04-10
WO2008043962A1 (fr) 2008-04-17
PL2081944T3 (pl) 2010-12-31
ZA200903193B (en) 2010-03-31
AU2007306226C1 (en) 2012-06-28
FR2907121B1 (fr) 2012-05-04
DE602007007653D1 (de) 2010-08-19
JP2010505923A (ja) 2010-02-25
IL197769A (en) 2013-07-31
ATE473233T1 (de) 2010-07-15
US20100075912A1 (en) 2010-03-25
CY1110787T1 (el) 2015-06-10
EP2081944A1 (fr) 2009-07-29
CA2664569A1 (fr) 2008-04-17
KR20090079232A (ko) 2009-07-21
RU2009117467A (ru) 2010-11-20
AU2007306226B2 (en) 2012-01-19
IL197769A0 (en) 2009-12-24
ES2347020T3 (es) 2010-10-22
HK1131156A1 (en) 2010-01-15
PT2081944E (pt) 2010-08-31
US8158764B2 (en) 2012-04-17
FR2907121A1 (fr) 2008-04-18
AU2007306226A1 (en) 2008-04-17
SI2081944T1 (sl) 2010-11-30

Similar Documents

Publication Publication Date Title
EA200802008A1 (ru) Фармацевтические композиции
NO20083630L (no) Nye pyridinderivater
BRPI1012892A2 (pt) composto, e, composição farmacêutica.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
NO20091395L (no) Nye tiofenderivater
RS54217B1 (en) SOME TRIAZOLOPIRAZINS, THEIR COMPOSITIONS AND THE METHODS OF USING THEM
BRPI0719398A2 (pt) Composição farmacêutica.
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
BRPI0811718A2 (pt) Derivados de 3,3-espiroindolinona
EA201170227A1 (ru) Имидазолкарбоксамиды
BRPI0814745A2 (pt) Composição de produto.
DE602008005634D1 (de) 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
BRPI0815059A2 (pt) Derivado de 1,3-di-hidroisoindol
DK2081944T3 (da) Nye morfin-derivater
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
NO20091386L (no) Fenyloksyanilinderivater
BRPI0811431A2 (pt) Composição farmacêutica aquosa.
DK1911455T3 (da) Topiske, vaginale farmaceutiske sammensætninger
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble